Literature DB >> 30302350

Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak-Iowa, 2015-2016.

Mona Marin1, Tricia L Kitzmann2, Lisa James3, Patricia Quinlisk4, Wade K Aldous5, John Zhang1, Cristina V Cardemil1, Chris Galeazzi4, Manisha Patel1, Ismael R Ortega-Sanchez1.   

Abstract

BACKGROUND: The United States is experiencing mumps outbreaks in settings with high 2-dose measles-mumps-rubella (MMR) vaccine coverage, mainly universities. The economic impact of mumps outbreaks on public health systems is largely unknown. During a 2015-2016 mumps outbreak at the University of Iowa, we estimated the cost of public health response that included a third dose of MMR vaccine.
METHODS: Data on activities performed, personnel hours spent, MMR vaccine doses administered, miles traveled, hourly earnings, and unitary costs were collected using a customized data tool. These data were then used to calculate associated costs.
RESULTS: Approximately 6300 hours of personnel time were required from state and local public health institutions and the university, including for vaccination and laboratory work. Among activities demanding time were case/contact investigation (36%), response planning/coordination (20%), and specimen testing and report preparation (13% each). A total of 4736 MMR doses were administered and 1920 miles traveled. The total cost was >$649 000, roughly equally distributed between standard outbreak control activities and third-dose MMR vaccination (55% and 45%, respectively).
CONCLUSIONS: Public health response to the mumps outbreak at the University of Iowa required important amounts of personnel time and other resources. Associated costs were sizable enough to affect other public health activities.

Entities:  

Keywords:  MMR; cost; economic burden; mumps; outbreak; third dose

Year:  2018        PMID: 30302350      PMCID: PMC6171567          DOI: 10.1093/ofid/ofy199

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   3.835


  18 in total

Review 1.  MMR vaccination and disease elimination: the Finnish experience.

Authors:  Irja Davidkin; Mia Kontio; Mikko Paunio; Heikki Peltola
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

2.  Varicella outbreak reporting, response, management, and national surveillance.

Authors:  Jessica Leung; Alison Rue; Adriana Lopez; Ismael R Ortega-Sanchez; Rafael Harpaz; Dalya Guris; Jane F Seward
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

3.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Mumps and mumps vaccine: a global review.

Authors:  A M Galazka; S E Robertson; A Kraigher
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

5.  Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Authors:  George E Nelson; Annette Aguon; Engracia Valencia; Rita Oliva; Michele Leon Guerrero; Richard Reyes; Anna Lizama; Daryl Diras; Annakutty Mathew; E Jessica Camacho; Moryne-Nicole Monforte; Tai-Ho Chen; Abdirahman Mahamud; Preeta K Kutty; Carole Hickman; William J Bellini; Jane F Seward; Kathleen Gallagher; Amy Parker Fiebelkorn
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

6.  Recent resurgence of mumps in the United States.

Authors:  Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

7.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Huong Q McLean; Amy Parker Fiebelkorn; Jonathan L Temte; Gregory S Wallace
Journal:  MMWR Recomm Rep       Date:  2013-06-14

8.  Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine.

Authors:  Charles W LeBaron; Bagher Forghani; Carol Beck; Cedric Brown; Daoling Bi; Cynthia Cossen; Bradley J Sullivan
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

9.  Mumps outbreak in Orthodox Jewish communities in the United States.

Authors:  Albert E Barskey; Cynthia Schulte; Jennifer B Rosen; Elizabeth F Handschur; Elizabeth Rausch-Phung; Margaret K Doll; Kisha P Cummings; E Oscar Alleyne; Patricia High; Jacqueline Lawler; Andria Apostolou; Debra Blog; Christopher M Zimmerman; Barbara Montana; Rafael Harpaz; Carole J Hickman; Paul A Rota; Jennifer S Rota; William J Bellini; Kathleen M Gallagher
Journal:  N Engl J Med       Date:  2012-11-01       Impact factor: 91.245

10.  Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.

Authors:  Mona Marin; Mariel Marlow; Kelly L Moore; Manisha Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-12       Impact factor: 17.586

View more
  2 in total

1.  Cost of Responding to the 2017 University of Washington Mumps Outbreak: A Prospective Analysis.

Authors:  Jamison Pike; Sheryl Schwartz; Meagan Kay; Ailyn Perez-Osorio; Mona Marin; Mark Jenkins; Janell Routh; Jeff Duchin; Chas DeBolt; Fangjun Zhou
Journal:  J Public Health Manag Pract       Date:  2020 Mar/Apr

2.  2016-2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies.

Authors:  Jamison Pike; Mona Marin; Angela Guo; Dirk Haselow; Haytham Safi; Fangjun Zhou
Journal:  Vaccine       Date:  2019-12-06       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.